The β-TrCP-Mediated Pathway Cooperates with the Keap1-Mediated Pathway in Nrf2 Degradation In Vivo

Ayumi Kuga1, Kouhei Tsuchida1, Harit Panda1

  • 1Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.

Insights

The Keap1-mediated and β-TrCP-mediated pathways regulate Nrf2 activity. A specific Nrf2 mutation revealed β-TrCP pathway cooperation, particularly when Keap1 is profoundly suppressed, leading to esophageal hyperplasia.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that activates cytoprotective genes.
  • Nrf2 activity is primarily regulated by two protein degradation pathways: Keap1-mediated and β-TrCP-mediated.
  • Understanding the interplay between these degradation pathways is crucial for comprehending Nrf2 regulation.

Purpose of the Study:

  • To investigate the relative contributions of the Keap1-mediated and β-TrCP-mediated pathways in regulating Nrf2 activity.
  • To characterize the physiological consequences of disrupting the β-TrCP-mediated Nrf2 degradation pathway.
  • To elucidate the cooperative roles of Keap1 and β-TrCP in controlling Nrf2 levels and function.

Main Methods:

  • Generation of knock-in mouse lines expressing an Nrf2 mutant (Nrf2SA) with substitutions affecting β-TrCP interaction.
  • Crossbreeding Nrf2SA mutant mice with Keap1 knockdown mouse models at varying knockdown levels.
  • Assessment of Nrf2 levels, Nrf2 activity, and phenotypic changes including growth and tissue morphology.

Main Results:

  • Homozygous Nrf2SA mice exhibited normal growth and Nrf2 levels under unstressed conditions.
  • Suppression of Keap1 activity led to significantly higher Nrf2 accumulation in Nrf2SA macrophages compared to wild-type.
  • Profound Keap1 knockdown in Nrf2SA mice resulted in severe growth retardation and esophageal hyperplasia/hyperkeratosis, linked to increased Nrf2 activity.
  • Moderate Keap1 suppression did not cause evident growth retardation or activation abnormalities.

Conclusions:

  • The β-TrCP-mediated pathway cooperates with the Keap1-mediated pathway in regulating Nrf2 activity.
  • This cooperation is most apparent and physiologically significant when the Keap1-mediated pathway is profoundly suppressed.
  • Disruption of β-TrCP-mediated Nrf2 regulation, especially under conditions of severe Keap1 deficiency, can lead to specific pathological changes, notably in the esophageal epithelium.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.7K